Get Instant Loan up to ₹10 Lakh!
Pharma sales remain flat, grow 0.2% in Jul
The fall in sales of acute therapy drugs indicates that people are avoiding visiting doctors at clinics and hospitals
Medicine sales in India were almost flat in July on a year-on-year basis although it has recovered since the March to May period when the country was under a strict lockdown, showed data from market researcher AIOCD-AWACS.
July drug sales were up 0.2% y-o-y to ₹12,124 crore, with cardiac care and anti-diabetic drugs posting healthy growth, albeit at a slower pace compared to June. Growth was on account of chronic medicines as sale of acute therapies remained suppressed. Sale of cardiovascular drugs were up 13.1%, at a slightly slower growth rate compared to 13.9% in June, while anti-diabetic drugs posted 5.9% growth compared to 8.5% in the preceding month.
However, anti-infectives continued to stay in the red for the fourth straight month, down 10.2%. Sales of another acute therapy segment, gastrointestinal drugs, also declined 2.4%.
The fall in sales of acute therapy drugs indicates that people are avoiding visiting doctors at clinics and outpatient departments of hospitals, with the fear of contracting coronavirus.
Catch all the Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
MoreLess
First Published:9 Aug 2020, 08:42 PM IST
- Top Gainers
- Top Losers
- 52 Week High